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The main aetiology of cervical cancer is infection with high risk human papillomavirus (HPV). 
Cervical cancer is almost 100% curable if detected in the early stages. Thus, information about the 10 
presence and levels of HPV in patient samples has high clinical value. As current screening 
methods, such as the Pap smear test, are highly subjective and in many cases show low sensitivity 
and specificity, new supportive techniques are desirable to improve the quality of cervical cancer 
screening. In this study, vibrational spectroscopic techniques (Raman and Fourier Transform Infra 
Red absorption) have been applied to the investigation of four cervical cancer cell lines, HPV 15 
negative C33A, HPV-18 positive HeLa with 20-50 integrated HPV copies per cell, HPV-16 
positive SiHa with 1-2 integrated HPV strands per cell and HPV-16 positive CaSki containing 60-
600 integrated HPV copies per cell. Results show that vibrational spectroscopic techniques can 
discriminate between the cell lines and elucidate cellular differences originating from proteins, 
nucleic acids and lipids. Similarities between C33A and SiHa cells were exhibited in the Raman 20 
and infrared spectra and were confirmed by Principal Component Analysis (PCA). Analysis of the 
biochemical composition of the investigated cells, with the aid of PCA showed a clear 
discrimination between the C33A-SiHa group and HeLa and CaSki cell lines indicating the 
potential of vibrational spectroscopic techniques as support to current methods for cervical cancer 
screening. 25 
Introduction 
Cervical cancer is second only to breast cancer as the most 
common malignancy in women worldwide 1. The gradual 
progression of cervical cancer allows the application of 
screening and diagnostic programmes to detect neoplastic 30 
changes before invasive cancer develops. The Papanicolaou 
test (also called the Pap test, Pap smear, or smear test) is a 
screening method which allows detection of infections and 
abnormalities of the cervix. The Pap smear test is the most 
widespread screening method for cervical neoplasia 2 and is 35 
based on visual evaluation of the morphology of cells 
collected from the cervix under light microscopy. Microscopic 
examination brings subjectivity to the screening results, 
therefore, the smear test has a hugely variable sensitivity 
(17% - 99%) and specificity (9% - 100%) 3.  40 
The probability of developing cervical dysplasia is much 
higher for women infected with human papillomavirus (HPV) 
than those free of infection 4. Infection with oncogenic or 
high- risk HPV (HPV-16, HPV-18) is the main risk factor for 
cervical cancer 5 with 99.7% of invasive cervical neoplasia 45 
associated with HPV infection 6. Thus, HPV testing has been 
added to the range of clinical options for cervical cancer 
screening. Detection of HPV (HPV testing) is based on 
detecting the DNA of the virus. It has been found that the 
DNA of high risk strains of HPV are assimilated within the 50 
cellular DNA of the host 7.  A drawback to HPV testing is that 
it is more expensive and time-consuming than other screening 
tests, and it requires a sophisticated laboratory infrastructure. 
Identifying the presence of HPV is a very important factor in 
the prevention of cervical cancer. Technologies such as 55 
fluorescence or vibrational spectroscopies are being 
investigated as potential high sensitivity and specificity 
methodologies for cancer screening and diagnosis 8-13.  
Vibrational spectroscopy is a molecular specific spectroscopy 
in which normal vibrational modes specific to molecular 60 
bonds as well as more complex molecular fingerprints are 
probed. There are two main vibrational spectroscopy 
techniques, Raman spectroscopy and infrared spectroscopy 
(IR), which give complementary spectral information. 
Vibrational spectroscopy is a powerful method delivering 65 
information about the chemical composition of a sample. 
Biomedical applications of vibrational spectroscopy are 
rapidly developing and it has been utilised in many studies to 
the detection of different types of cancer 14-20. In the literature, 
there is a wide spectrum of experiments concerning cervical 70 
cancer investigation with vibrational spectroscopy techniques, 
demonstrating the usefulness of these methods in 
understanding cervical cancer progression from the molecular 
level, and showing its potential application in cervical cancer 
screening and diagnosis 21-43. Raman spectroscopy has also 75 
been used to study cell lines derived from the cervix, 
revealing spectral variations, mostly in peaks originating from  
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Fig. 1 Mean Raman spectra of cervical cancer cell lines. 
DNA and proteins, in cell lines expressing the E7 gene of 
HPV-16 compared to cells not affected by HPV 44. 
Furthermore, a recent study has demonstrated that in low-5 
grade cytology infected with high-risk oncogenic HPV16 or 
HPV18, it was possible to differentiate samples from women 
based on whether they were aged 20–29 years vs. 30–39 years 
using attenuated total reflection infrared spectroscopy 45. 
In our study, four cervical cancer cell lines were investigated; 10 
HPV negative C33A, HPV-18 positive HeLa with 20-50 
integrated HPV copies per cell, HPV-16 positive SiHa with 1-
2 integrated HPV strands per cell and HPV-16 positive CaSki 
containing 60-600 integrated HPV copies per cell.  The main 
aim of the experiment was to investigate biochemical changes 15 
in cells caused by high risk HPV strands (HPV-16 and HPV-
18) and to examine whether it is possible to differentiate 
between the cells with no HPV copies and cells infected by 
low number, medium number and high number of integrated 
HPV copies, using vibrational spectroscopic techniques. Both 20 
common forms of vibrational spectroscopy, Raman and 
Fourier Transform Infrared absorption, were used to gain 
complementary information. 
Materials and Methods 
Cell culturing 25 
Cell lines were obtained from the ATCC cell culture 
collections. All cell lines were grown in RPMI 1640 medium 
(Sigma-Aldrich, Ireland) supplemented with 10% Foetal 
Bovine Serum (FBS, BioWhittaker®, Lonza, Ireland), 1% 
Penicillin-Streptomycin (BioWhittaker®, Lonza, Ireland), 1% 30 
L-glutamine (Sigma-Aldrich, Ireland), and 0.2% 
Hydrocortisone (Sigma-Aldrich, Ireland). Cells were 
incubated at 37°C in 5% CO2 and maintained up to 70-80% 
confluency. 
Sample preparation 35 
For Raman measurements, cervical cells were detached from 
the flasks using Trypsin – EDTA concentration (Sigma-
Aldrich, Ireland) and centrifuged at 1200rpm for 5 minutes. 
After removing the supernatant, cells were washed twice in  
 40 
Fig. 2 (A) - Mean FTIR spectra of cervical cancer cell lines. (B) - FTIR 
spectra of cervical cancer cell lines in the range of 1000 to 1100cm-1. 
Peak I, assigned to a (C-C) protein vibration, exhibits differences in 
intensity for CaSki cells, while peak II at 1072cm-1 assigned to 
DNA/RNA shows a different intensity for the C33A cell line and a slight 45 
shift for C33A and SiHa in comparison to HeLa and CaSki. 
PBS and centrifuged at 1200rpm for 6 minutes after each 
wash. Finally, the supernatant was removed and cellular 
pellets were transferred onto glass slides. The number of cells 
transferred to one slide was in the range of 2-3×107 cells, 50 
yielding a pellet of dimensions ~8×8×4 mm. Cells for FTIR 
study were grown for 24 hours on CaF2 windows. Cells 
prepared for Raman and FTIR measurements were not fixed to 
avoid distortion of the cellular spectra 46. Before FTIR 
measurements, cells were washed twice in PBS and dried at 55 
50°C to minimise contributions from water. Although cellular 
proteins can undergo denaturation at such temperatures, all 
cell lines were treated in exactly the same manner, allowing 
comparison of the spectroscopic features of the cell lines 
investigated. Raman signals were accumulated from an 60 
undried pellet and in both cases the time between removal 
from the incubator to spectral measurement was minimised to 
20-25mins. 
Raman measurements 
Raman studies were performed using a Horiba J-Y Labram 65 
HR800 system operating with the 532nm Argon ion laser line. 
The laser power at the sample was measured and found to be 
37.00 ±0.05mW. The backscattered light was collected by the 
objective lens and dispersed onto an air cooled CCD detector 
(1024x256 pixels) by the grating. The dispersion of the 70 
system for the 600 lines/mm grating was ~2cm-1/pixel. A ×50 
objective lens was used for the measurements giving a spot 
size of ~1μm. Raman signals from two cellular pellets 
representing two cell culture passages were integrated for 60 
seconds and measured over a spectral range of 400 to 1900cm-75 
1. Random target areas within the pellets were chosen during 
the measurements. The thickness of the cellular pellets 
(~4mm) was high enough to avoid contribution from the glass 
slide in the collected biological spectra. However, this was 
only possible during the first 30-40 minutes of the 80 
measurements while the cellular material was not dried and 
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Table 1 Peak assignments 47 for Raman spectra data recorded for cervical cancer cell lines. 
Peak reference (figure 1) Wavenumber (cm-1) Raman peak assignments 
1 621 C-C twisting mode of Phe (proteins) 
2 642 C-C twisting mode of Tyr and Phe 
3 670 C, T,G (DNA/RNA) 
4 720 C-N stretching in A and lipids 
5 750 symmetric breathing of Trp (protein) 
6 782 U, T, C (ring breathing modes in the DNA/RNA) 
7 827 PO2 stretching in DNA, Tyr 
8 854 Ring breathing in Tyr and Pro (proteins) 
9 935 C-C stretching mode of Pro and Val 
10 1003 C-C aromatic ring stretching in Phe 
11 1031 C-H bending mode in Phenylalanine, C-N stretching in proteins 
12 1093 symmetric PO2 stretching of the DNA backbone; lipids 
13 1128 C-N stretching in proteins; C-O stretching in carbohydrates 
14 1155 C-C and C-N stretching of proteins 
15 1175 C-H in plane bending mode of Tyr and Phe; C, G 
16 1208 C-C6H5 stretching mode in Trp, Phe; 
17 1220-1280 Amide III; A,C,T ring breathing modes of the DNA/RNA 
18 1311 CH3/CH2 twisting mode of collagen and lipid 
19 1340 G (DNA/RNA), CH deformation in proteins and carbohydrates; Trp 
20 1450 CH (CH2) bending mode in proteins and lipids 
21 1583 A,G (DNA/RNA); C=C bending mode of Phe 
22 1618 C=C Phe, Tyr and Trp 
23 1550-1700 H2O bending mode 
24 1620-1700 Amide I 
 
the thickness of the pellet exceeded 3mm.  
FTIR measurements 
FTIR measurements were performed using a Perkin Elmer 5 
Spotlight 400 microscope system in Transmission Mode. 
Spectra were collected as an average of 64 scans with a 
resolution of 2cm-1. FTIR signals were accumulated over a 
spectral range of 1000 to 4000cm-1. An aperture of 
100×100µm was set on groups of 15-20 cells. Two pellets of 10 
each cell lines (two cell culture passages) were investigated. 
Data analysis 
Data analysis was performed in Matlab, version R2006 
(Mathworks, CA, USA) according to protocols developed in 
house. Processing of the raw Raman spectra included baseline 15 
correction according to an in house automated rubber band 
model, Extended Multiplicative Signal Correction (EMSC) 
and 5th order Savitzky-Golay filtering with 13 point window. 
Processing of the FTIR spectra involved EMSC resonant Mie 
scattering correction according to the algorithm developed by 20 
Bassan et al. 48. The Matrigel spectrum supplied with the 
algorithm was used as reference. 
After pre-processing the spectra, Principal Component 
Analysis (PCA) was applied to the data set. PCA is a 
multivariate statistical technique used for dimensionality 25 
reduction and exploratory analysis and has become a very 
useful tool for spectroscopists allowing for objective 
interpretation of vibrational spectroscopic data.  
Results and Discussion 
Mean spectra analysis 30 
The mean of 30 Raman spectra recorded from two pellets 
(approximately 15 spectra per pellet) for C33A, SiHa, HeLa 
and CaSki cell lines were derived from the raw spectra via the 
pre-processing procedures and are presented in figure 1. 
Assignments of the main peaks (numbered in figure 1) are 35 
shown in table 1. In the mean Raman spectra, almost no 
significant differences between HPV negative C33A and SiHa 
cells, containing 1-2 HPV copies per cells (low HPV 
concentration) are discernible. Only the peak at 1583cm-1 
assigned to DNA/RNA and Phenylalanine vibrations was 40 
found to vary between C33A and SiHa cells. For cells 
containing a higher number of integrated HPV copies per cell, 
HeLa cells (medium HPV concentration) and CaSki cells 
(high HPV concentration), the observed differences are more 
prominent for protein, nucleic acid and lipid vibrations. CaSki 45 
cells exhibited a significant increase in Amide I (proteins) 
intensity at 1660cm-1 and a decrease in lipid levels at 1093cm-
1, 1311cm-1 and 1450cm-1 compared to C33A, SiHa and HeLa. 
HPV presence in a cell appears to change protein expression, 
which may result in the protein variations observed in the 50 
Raman spectra, primarily for the Amide I region. Further 
differences in protein vibrations between the cells affected by 
non- and low HPV number compared to medium and high 
HPV number were observed in the Amide III region (1254cm-
1), and protein constituent amino acids Tryptophan (Trp), 55 
Proline (Pro), Tyrosine (Tyr) and Phenylalanine (Phe) 
vibrations at 854cm-1, 935cm-1, 1003cm-1, 1583cm-1 and 
1618cm-1. Variations in vibrations associated with nucleic 
 4  |  Journal Name, [year], [vol], 00–00 This journal is © The Royal Society of Chemistry [year] 
Table 2  Peak assignments 50 for FTIR spectra data recorded for cervical cancer cell lines. 
Peak reference (figure 2) Wavenumber (cm-1) FITR peak assignments 
I 1036 C-C skeletal stretching (proteins) 
II 1072 PO2 symmetric stretching (DNA/RNA) 
III 1152 C-C and C-O stretching (proteins) 
IV 1220-1280 PO2 asymmetric stretching (DNA/RNA), Amide III  
V 1312 CH2 stretching (phospholipids) 
VI 1400 CH3 symmetric stretching (proteins) 
VII 1456 CH3 asymmetric stretching (proteins) 
VIII 1546 Amide II 
IX 1620-1700 Amide I  
X 1742 Ester, C=O stretching (lipids) 
XI 2854 CH2 symmetric stretching (lipids) 
XII 2926 CH2 asymmetric stretching (lipids) 
XIII 2964 CH3 asymmetric stretching (lipids and proteins) 
XIV 3296 NH asymmetric stretching (proteins), Amide A 
 
acid constituents: PO2 group, A, C, T, U at 1093cm-1, 720cm-
1, 782cm-1, 1254cm-1, 1583cm-1 respectively were also 
observed. The differences in protein and nucleic acid 5 
composition support the molecular data which demonstrates 
intergration of HPV DNA at chromosome fragile sites and the 
subsequent downstream effect of HPV E6 and E7 oncoprotein 
expression on host cell proteins such as p53 49.  
Approximately 30 infrared signal acquisitions were performed 10 
from each investigated sample representing the cell line, 
giving in total 60 characteristic spectra recoreded from two 
pellets for every cell line. Mean FTIR spectra for the 
investigated cell lines derived by the preprocessing procedure 
are shown in figure 2, with corresponding numbered 15 
assignments presented in table 2. Although the Resonant Mie 
subtraction procedure cannot be considered perfect, as 
evidenced by the residual background in the region of 
~1800cm-1 to 2800cm-1 and the small sharp dips at 1735cm-1 
and 2845cm-1, significantly improved spectra were produced 20 
after just one iteration of the algorithm. C33A and SiHa cell 
lines are again seen to be spectrally very similar, exhibiting 
just a small difference in the peak at 1072cm-1 corresponding 
to nucleic acid vibration (figure 2B). Similar to the Raman 
results, differences between C33A, SiHa compared to the 25 
HeLa, CaSki cell lines were observed in the FTIR spectra for 
protein, nucleic acid and lipid levels.  
Variations in protein levels are manifest in variations of the 
peaks at 1036cm-1 (figure 2B), and the amide bands; Amide 
III (1242cm-1), Amide II (1546cm-1), Amide I (1652cm-1) and 30 
Amide A (3296cm-1). DNA/RNA variations are primarily 
expressed through the band at 1242cm-1, assigned to the PO2 
group vibration. Differences in bands corresponding to lipid 
vibrations at 1740cm-1 and in the region above 2800cm-1 are 
also observed.  The peak around 1740cm-1 is associated with 35 
vibrations of lipid esters and is known to indicate active 
growth of cells 51. The intensity of the ester peak was found to 
be the highest for CaSki cell line. This is consistent with the 
fact that CaSki cells are derived from a metastatic tumour. 
Multivariate statistical analysis 40 
The principal component (PC) scatterplot for Raman 
spectroscopic results presented in figure 3A shows a 
distinctive separation between the cell lines, suggesting a 
HPV concentration dependence factor. The C33A (non HPV) 
and SiHa (low HPV concentration, LC) cell lines are grouped 45 
together, confirming observed similarities between these two 
types of cells based on mean spectra analysis. The HeLa 
(medium HPV concentration, MC) and CaSki (high HPV 
concentration, HC) cell lines are clearly separated from each 
other and from the C33A-SiHa group. Although the 3D PCA 50 
scatterplot demonstrates the HPV concentration dependent 
separation, the cell lines are not grouped according to 
increasing (or decreasing) number of HPV copies. CaSki (HC) 
cells lie between HeLa (MC) and SiHa (LC). This suggests 
the influence on the data point distribution of another factor – 55 
HPV strand type. HeLa are cells infected by HPV-18, while 
CaSki and SiHa are infected by HPV-16. Principal component 
loadings are presented in figure 3B. Peak numbers correspond 
to assignments presented in table 1. The percent of variance 
explained by PC1, PC2 and PC3 is 71.9%, 10.8% and 6.2%, 60 
respectively. The first principal component is dominated by 
the contribution of the H-O-H bending of water, a broad peak 
in the range of 1550-1700cm-1 with maximum at ~1644cm-1 
52.  Water is not, however, the only potential contribution 
within this range, as Amide I vibrations (β-sheet) exhibited a 65 
maximum at 1640cm-1. Nucleic acid contributions to PC1 may 
also be present at 782cm-1, 1093cm-1 and 1583cm-1 although it 
is very difficult to judge what is the percentage of 
contribution of each of these components. The second 
principal component shows predominantly protein and lipid 70 
contributions. Lipids are exhibited at 1095cm-1, 1310cm-1 and 
1450cm-1, while proteins are at 1660cm-1 – Amide I (α-helix), 
1270cm-1 - Amide III (α-helix), 1450cm-1, C=C Phe at 
1582cm-1 and Trp at 750cm-1. The third principal component 
contains a lot of biological information with mainly nucleic 75 
acid and protein contributions but only accounts for 6.2% of 
variance. There are distinctive peaks corresponding to nucleic 
acids and protein vibrations. DNA and RNA contributions are 
observed at 670cm-1, 720cm-1, 782cm-1, 1092cm-1, 1250cm-1, 
1340cm-1 and 1583cm-1. PC3 shows a strong influence of 80 
variation arising from protein vibrations, Phe (642cm-1,  
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Fig. 3 Principal component analysis for Raman spectroscopy results for 
cervical cancer cell lines.  (A) - Three dimensional PCA scatterplot. 
Graphs show separation of the cervical cancer cell lines suggesting HPV 
concentration dependence. (B) - Principal component loadings. Peak 5 
assignments correspond to those listed in table 1. 
1002cm-1, 1031cm-1, 1583cm-1 and 1618cm-1), Trp (1208cm-1, 
1340cm-1 and 1618cm-1), Tyr (642cm-1, 854cm-1 and 1618cm-
1), Pro (854cm-1, 935cm-1), Val (935cm-1), Amide I at 
1680cm-1 (disordered) and Amide III at 1260cm-1 10 
(disordered). The source of variations shown in the loadings is 
in very good agreement with those observed in the analysis of 
the mean spectra for the investigated cell lines. The main 
peaks in the loadings arise from protein, nucleic acid and lipid 
component vibrations. Each principal component is dominated 15 
by different cellular components; water, and possibly nucleic 
acids and proteins in PC1, lipids and proteins in PC2 and 
nucleic acids and proteins in PC3. Amide I and Amide III 
contributions are present in all principal component loadings 
indicative of differences in structural conformation of the 20 
protein β-sheet in PC1, α-helix in PC2 and disordered 
conformation in PC3. As mentioned previously, variations in 
protein, nucleic acid and lipid levels arise from the fact that 
the viral DNA interacts with the cellular DNA, causing 
reprogramming of protein expression in the cell.  25 
It was noted that the multivariate analysis could be 
sustantially influenced by water contributions in the region of 
1640cm-1. Repeated over the spectral range 400-1550cm-1, the 
PCA gave a similar separation of the cellular types and 
yielded similar principle components. 30 
Figure 4A shows the three dimensional PCA scatterplot for 
FTIR spectroscopic results and two dimensional presentation 
of the plot for the cervical cancer cell lines. It can be clearly 
seen that the groups of points representing the different types 
of cells are separated from each other. HPV negative C33A 35 
and SiHa cell line (LC HPV) are grouped very closely in the 
scatterplot, which is consistent with the PCA of the Raman 
spectroscopic data for the same cells. Cell lines with greater 
 
 40 
Fig. 4 Principal component analysis for FTIR spectroscopy results for 
cervical cancer cell lines. (A) - Three dimensional PCA scatterplot 
showing data points separation according to HPV concentration. (B) - 
Principal component loadings exhibiting variations for the defined nucleic 
acid, protein and lipid bands. 45 
than 20 HPV copies (HeLa and CaSki) are separated from the 
C33A and SiHa cells. The data distribution pattern for FTIR 
spectra is very similar to that seen for Raman spectra, 
demonstrating a HPV concentration dependence. Principal 
component loadings are presented in figure 4B and confirm 50 
the variations observed for the mean spectra of the cell lines. 
The percentage variance accounted for by the three first 
principal components is 81.3%, 12.6% and 3.7%, for PC1, 
PC2 and PC3, respectively. All three principal components 
show variations for the peaks assigned to proteins, primarily 55 
the amide bands. Significantly, in the regions of the Amide I 
and Amide III bands, every PC exhibits a peak corresponding 
to variations of the different conformational structures of the 
protein. In PC1, changes to the contributions of β-sheet 
conformations are expressed in the Amide I (1646cm-1) and 60 
Amide III (1240cm-1) bands, an observation which lends 
support to the Raman assignments. In PC 2, changes to α-
helix contributions are observed in the Amide I region 
(1660cm-1) and in PC3, changes to disordered structure 
vibrations in Amide I (1686cm-1) and Amide III (1260cm-1). 65 
Changes to the Amide II bands are apparent in PC2 and PC3 
at 1548cm-1 and 1546cm-1, respectively.  
With respect to PC3, there is a separation of the CaSki group 
from the other cell lines and it is important to note that in the 
PC3 loading there is a distinctive protein peak at 1036cm-1, 70 
which has a clearly different contribution in the CaSki mean 
spectrum compared to other cell lines (figure 2B). 
Bands corresponding to changes in nucleic acid vibrations are 
also exhibited in all principal component loadings (1072cm-1, 
1242cm-1) again suggesting the interaction of cellular and 75 
viral DNA. PC’s show also a lipid contribution manifest very 
clearly in the range of 2850cm-1 – 2970cm-1. Similar to the 
Raman spectroscopic results, the lowest intensity of lipid 
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peaks were observed for the CaSki cell line. Lipid variations 
may be due to interaction of high risk HPV with the plasma 
membrane, which has a direct influence on lipid rafts 53. 
Conclusions 
Vibrational spectroscopic techniques have been applied to the 5 
analysis of cervical cancer cell lines (C33A, SiHa, HeLa and 
CaSki) delivering complementary information about the 
biochemical composition of the investigated samples. Mean 
Raman and FTIR spectra of C33A and SiHa cells are very 
similar indicating that cells not infected by HPV and those 10 
affected by a very low number of HPV copies are 
biochemically very similar. Very subtle differences for these 
cell lines were observed for the peaks assigned to nucleic acid 
vibrations and they are well differentiated by PCA of the two 
data sets alone (data not shown). This fact suggests that 15 
although the cell lines are very similar, there is a change in 
the cellular DNA/RNA, possibly due to the fact of integration 
of cellular DNA with 1-2 copies of HPV DNA for SiHa cells. 
PCA confirms the observations about the similarities between 
these two cell lines, grouping C33A and SiHa cells close to 20 
each other in the PCA scatterplot.  
Mean Raman and FTIR spectra of the cells containing a 
higher number of HPV copies, HeLa and CaSki significantly 
differ from the signals recorded from C33A and SiHa. 
Variations observed in protein, nucleic acid and lipid levels 25 
were also confirmed by PCA analysis. Variations of Raman 
peaks assigned to Trp, Pro, Tyr and Phe are remarkable, and 
are in good agreement with the observation made by Jess et al 
of differences between HPV positive (PHK E7) and HPV 
negative cell lines (PHK) based on peaks assigned to Phe, Pro 30 
and Tyr 44.  
Raman and FTIR PCs are dominated by features associated 
with changes of protein conformation structures; β-sheet, α-
helix and disordered structure in PC1, PC2 and PC3, 
respectively. A decrease in lipid levels were observed in the 35 
Raman and FTIR signals for the CaSki cell line. The observed 
changes in proteins are evidence that HPV influences protein 
balance within the cell resulting in under- and over expression 
of certain proteins, while, lipid peak variations are possibly 
due to disruption of the membrane functionality by the virus. 40 
PCA applied to Raman and FTIR results has successfully 
discriminated all cervical cancer cell lines indicating HPV 
concentration dependence between cells with no and low 
number (0-2) of HPV copies per cell (C33A, SiHa), medium 
number (10-50) of HPV copies per cell (HeLa) and high 45 
number (60-600) of HPV copies per cell (CaSki). In summary, 
our results show that vibrational spectroscopy and PCA can 
discriminate between the cells affected by the various number 
of HPV copies and confirm the FTIR study of Kelly at al. on 
cervical cells 45. The biochemical origins of the discrimination 50 
can also be elucidated. The knowledge about differences in 
Raman and FTIR spectra between the HPV negative cells and 
these affected by various numbers of HPV copies is very 
important and has potential application in systems for cervical 
cancer screening based on vibrational spectroscopic 55 
techniques. This new technology for cervical screening not 
only can distinguish cervical cells based on biochemical 
content but also can elucidate the effect of HPV on the cells. 
It is noted, however, that the sample preparation protocol for 
each technique is different and in both cases less than ideal, 60 
and that a pellet preparation protocol which preserves the 
biochemical integrity of the cells is desirable. 
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